Core One Labs Stock Price, News & Analysis

CLABF OTC Link

Company Description

Core One Labs (OTC Link: CLABF) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $4.9M.

CLABF stock has declined 100.0% over the past year. Shares last traded at $0.0000.

This page provides a comprehensive overview of CLABF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-100%

Performance 1 year

$4.9M

Market Cap

47.1M

Shares outstanding

Core One Labs (CLABF) stock last traded at $0.0000. Over the past 12 months, the stock has lost 100.0%. At a market capitalization of $4.9M, CLABF is classified as a micro-cap stock with approximately 47.1M shares outstanding.

Latest News

View All

December 8, 2023

+30.20%

Core One Labs Inc. Announces Initial Agreement for Potential Sale of Proprietary Biosynthetic Psilocybin, Facilitating Entry into the International Market

December 2, 2023

+35.25%

Core One Labs’ Akome Reveals Impressive Results for its Psychedelic Bio-Compounds Designed to Target Alzheimer’s and Parkinson’s, Showing Potential to Outperform Current Treatment Methods

August 4, 2023

+11.08%

Core One's Akome Reveals Groundbreaking Positive Results from its Second Round of Stage 1 Animal Model Studies for Bio-Compounds Targeting Alzheimer’s and Parkinson's Disease

August 1, 2023

+1.57%

Core One Labs', Awakened Biosciences, Announces Groundbreaking Step Forward in Isolating and Purifying Psilocybin from Mushroom Biomass

July 28, 2023

+5.85%

Core One's Akome Receives Positive Preliminary Stage 1 Animal Model Study Results for Bio-Compound Targeting Alzheimer’s and Parkinson’s Disease

July 11, 2023

-7.50%

Core One's Vocan Biotechnologies Incorporates New Bioreactor Equipment into Production Process Significantly Increasing Throughput of Proprietary Biosynthetic Psilocybin

Core One Labs has 10 recent news articles. Of the recent coverage, 9 articles coincided with positive price movement and 1 with negative movement. View all CLABF news →

SEC Filings

View All

No SEC filings available for CLABF.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Short interest in Core One Labs (CLABF) currently stands at 1.8 thousand shares, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 44.5%. This relatively low short interest suggests limited bearish sentiment.

Days to Cover History

Last 12 Months

Days to cover for Core One Labs (CLABF) currently stands at 1.0 days, down 24.2% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.

CLABF Company Profile & Sector Positioning

Core One Labs (CLABF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.

Investors comparing CLABF often look at related companies in the same sector, including Orgenesis Inc (ORGS), Vaxxinity, Inc. (VAXX), Kane Biotech Inc (KNBIF), Sigyn Therapeutics Inc (SIGY), and Biophytis Sa (BPTSY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CLABF's relative position within its industry.

Frequently Asked Questions

What is the current stock price of Core One Labs (CLABF)?

The current stock price of Core One Labs (CLABF) is $0.000001 as of March 4, 2026.

What is the market cap of Core One Labs (CLABF)?

The market cap of Core One Labs (CLABF) is approximately 4.9M. Learn more about what market capitalization means .